Chief Science Officer
Edward Grant is Co-Founder and Chief Science Officer at Rahko, a London-based quantum drug discovery company. Rahko combines three technologies: computational quantum chemistry, quantum machine learning and quantum computing to deliver state-of-the-art in drug discovery with AI today and quantum computing tomorrow. Edward has a research background in neural network and quantum machine learning method development.
Determining the stability of molecules and condensed phases is the cornerstone of atomistic modeling, underpinning our understanding of chemical and materials properties and transformations....